Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An overview and a roadmap for artificial intelligence in hematology and oncology.
Rösler W, Altenbuchinger M, Baeßler B, Beissbarth T, Beutel G, Bock R, von Bubnoff N, Eckardt JN, Foersch S, Loeffler CML, Middeke JM, Mueller ML, Oellerich T, Risse B, Scherag A, Schliemann C, Scholz M, Spang R, Thielscher C, Tsoukakis I, Kather JN. Rösler W, et al. Among authors: spang r. J Cancer Res Clin Oncol. 2023 Aug;149(10):7997-8006. doi: 10.1007/s00432-023-04667-5. Epub 2023 Mar 15. J Cancer Res Clin Oncol. 2023. PMID: 36920563 Free PMC article. Review.
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL.
Staiger AM, Altenbuchinger M, Ziepert M, Kohler C, Horn H, Huttner M, Hüttl KS, Glehr G, Klapper W, Szczepanowski M, Richter J, Stein H, Feller AC, Möller P, Hansmann ML, Poeschel V, Held G, Loeffler M, Schmitz N, Trümper L, Pukrop T, Rosenwald A, Ott G, Spang R; Emed Demonstrator Project; German High Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL). Staiger AM, et al. Among authors: spang r. Leukemia. 2020 Feb;34(2):543-552. doi: 10.1038/s41375-019-0573-y. Epub 2019 Sep 17. Leukemia. 2020. PMID: 31530861 Clinical Trial.
Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy.
Leich E, Brodtkorb M, Schmidt T, Altenbuchinger M, Lingjærde OC, Lockmer S, Holte H, Nedeva T, Grieb T, Sander B, Sundström C, Spang R, Kimby E, Rosenwald A. Leich E, et al. Among authors: spang r. Leuk Lymphoma. 2023 Dec;64(12):1927-1937. doi: 10.1080/10428194.2023.2240462. Epub 2023 Sep 8. Leuk Lymphoma. 2023. PMID: 37683053
Anomaly detection in mixed high-dimensional molecular data.
Buck L, Schmidt T, Feist M, Schwarzfischer P, Kube D, Oefner PJ, Zacharias HU, Altenbuchinger M, Dettmer K, Gronwald W, Spang R. Buck L, et al. Among authors: spang r. Bioinformatics. 2023 Aug 1;39(8):btad501. doi: 10.1093/bioinformatics/btad501. Bioinformatics. 2023. PMID: 37584673 Free PMC article.
BITES: balanced individual treatment effect for survival data.
Schrod S, Schäfer A, Solbrig S, Lohmayer R, Gronwald W, Oefner PJ, Beißbarth T, Spang R, Zacharias HU, Altenbuchinger M. Schrod S, et al. Among authors: spang r. Bioinformatics. 2022 Jun 24;38(Suppl 1):i60-i67. doi: 10.1093/bioinformatics/btac221. Bioinformatics. 2022. PMID: 35758796 Free PMC article.
Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation.
Sorrentino A, Menevse AN, Michels T, Volpin V, Durst FC, Sax J, Xydia M, Hussein A, Stamova S, Spoerl S, Heuschneider N, Muehlbauer J, Jeltsch KM, Rathinasamy A, Werner-Klein M, Breinig M, Mikietyn D, Kohler C, Poschke I, Purr S, Reidell O, Martins Freire C, Offringa R, Gebhard C, Spang R, Rehli M, Boutros M, Schmidl C, Khandelwal N, Beckhove P. Sorrentino A, et al. Among authors: spang r. J Immunother Cancer. 2022 May;10(5):e004258. doi: 10.1136/jitc-2021-004258. J Immunother Cancer. 2022. PMID: 35606086 Free PMC article.
Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA).
Hassel JC, Schank TE, Smetak H, Mühlbauer J, Salzmann M, Machiraju D, Menzer C, Lang K, König L, Haefner MF, Hülsmeyer I, Kohler C, Spang R, Enk A, Debus J, Beckhove P. Hassel JC, et al. Among authors: spang r. Oncoimmunology. 2022 Apr 16;11(1):2066609. doi: 10.1080/2162402X.2022.2066609. eCollection 2022. Oncoimmunology. 2022. PMID: 35481285 Free PMC article.
164 results